Wednesday, July 8, 2026 The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Tesla, Inc.

Learn more Jonathan Wygant, Vice President and Chief Accounting Officer of Veracyte (NASDAQ:VCYT), reported the exercise of ...

Veracyte offers genomic diagnostic tests for cancer and other diseases, including Afirma, Decipher, Prosigna, Percepta, Envisia, and Immunoscore, with a focus on thyroid, prostate, breast, lung, and ...

(UroToday.com) The 2026 European Association of Urology (EAU) Annual Meeting held in London, U.K., between March 13 t h and 16 th 2026, was host to the Hormone-sensitive metastatic prostate cancer: ...

Tiny silica nanoparticles engineered to seek out prostate cancer caused tumor cells to self-destruct and supercharged the ...

In the United States, prostate cancer is a leading cause of cancer-related disease and death in men. About half of prostate cancer cases in patients of European ancestry have a gene rearrangement in ...

Black men are much more likely to die from prostate cancer than the general population. A group of Chicago-area researchers ...

Exact Imaging is looking to broaden uptake of its high-resolution micro-ultrasound system for prostate cancer screening and ...

Smart PSA boosted targeted screening and found more aggressive prostate cancers in Black men in Chicago trials.

Alicia Morgans, MD, MPH, and Charles Ryan, MD discuss Orgovyx and what it means to men being treated for advanced prostate cancer who now have an oral ADT treatment option. The FDA approval is based ...